Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jan 8;193(1):149-158.
doi: 10.1093/aje/kwac036.

Estimating Subgroup Effects in Generalizability and Transportability Analyses

Estimating Subgroup Effects in Generalizability and Transportability Analyses

Sarah E Robertson et al. Am J Epidemiol. .

Abstract

Methods for extending-generalizing or transporting-inferences from a randomized trial to a target population involve conditioning on a large set of covariates that is sufficient for rendering the randomized and nonrandomized groups exchangeable. Yet, decision makers are often interested in examining treatment effects in subgroups of the target population defined in terms of only a few discrete covariates. Here, we propose methods for estimating subgroup-specific potential outcome means and average treatment effects in generalizability and transportability analyses, using outcome model--based (g-formula), weighting, and augmented weighting estimators. We consider estimating subgroup-specific average treatment effects in the target population and its nonrandomized subset, and we provide methods that are appropriate both for nested and non-nested trial designs. As an illustration, we apply the methods to data from the Coronary Artery Surgery Study (North America, 1975-1996) to compare the effect of surgery plus medical therapy versus medical therapy alone for chronic coronary artery disease in subgroups defined by history of myocardial infarction.

Keywords: generalizability; heterogeneity of treatment effects; subgroup analysis; transportability.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Dahabreh IJ, Hernán MA. Extending inferences from a randomized trial to a target population. Eur J Epidemiol. 2019;34(8):719–722. - PubMed
    1. Cole SR, Stuart EA. Generalizing evidence from randomized clinical trials to target populations: the ACTG 320 trial. Am J Epidemiol. 2010;172(1):107–115. - PMC - PubMed
    1. Westreich D, Edwards JK, Lesko CR, et al. Transportability of trial results using inverse odds of sampling weights. Am J Epidemiol. 2017;186(8):1010–1014. - PMC - PubMed
    1. Dahabreh IJ, Robertson SE, Tchetgen EJ, et al. Generalizing causal inferences from individuals in randomized trials to all trial-eligible individuals. Biometrics. 2019;75(2):685–694. - PMC - PubMed
    1. Dahabreh IJ, Robertson SE, Steingrimsson JA, et al. Extending inferences from a randomized trial to a new target population. Stat Med. 2020;39(14):1999–2014. - PubMed

Publication types